ClinicalTrials.Veeva

Menu

Beijing Indoor Air Purifier Intervention Study (BIAPSY)

W

WeiHuang

Status

Completed

Conditions

Pulmonary Disease

Treatments

Other: air purifier

Study type

Interventional

Funder types

Other

Identifiers

NCT02509000
WHuang14

Details and patient eligibility

About

This study aimed to assess the impact of air filtration on indoor air quality and cardio-pulmonary health in residents living in high outdoor pollution settings in Beijing.

Enrollment

35 patients

Sex

All

Ages

40 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Global Initiative for Chronic Obstructive Lung Disease criteria (mild to moderate, GOLD stage I~II;
  • severe to very severe, GOLD stage III~IV) quit smoking for at least 1 year;
  • a ratio of pre-bronchodilator forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) equal to or less than 0.70 and an increase of FEV1 with the use of 400μg of albuterol of less than 12% of the pre-bronchodilator one;
  • no history of asthma or any other active lung disease.
  • Subjects were free from exacerbations for at least 6 weeks.

Exclusion criteria

  • Patients with heart pacemaker,
  • heart failure with bundle-branch block,
  • recent myocardial infarction (in the last 12 weeks) and
  • anticoagulant therapy

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

35 participants in 2 patient groups

Active-mode
Active Comparator group
Description:
Air purifier in active-mode
Treatment:
Other: air purifier
Sham-mode
Sham Comparator group
Description:
Air purifier in sham-mode
Treatment:
Other: air purifier

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems